News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,906 Results
Type
Article (45443)
Company Profile (474)
Press Release (698976)
Multimedia
Podcasts (126)
Webinars (20)
Section
Business (210520)
Career Advice (2244)
Deals (36313)
Drug Delivery (123)
Drug Development (84415)
Employer Resources (177)
FDA (16819)
Job Trends (15350)
News (356468)
Policy (33639)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2707)
Accelerated approval (37)
Adcomms (32)
Allergies (150)
Alliances (51430)
ALS (180)
Alzheimer's disease (1744)
Antibody-drug conjugate (ADC) (336)
Approvals (17051)
Artificial intelligence (559)
Autoimmune disease (167)
Automation (42)
Bankruptcy (375)
Best Places to Work (11905)
BIOSECURE Act (21)
Biosimilars (199)
Biotechnology (332)
Bladder cancer (165)
Brain cancer (63)
Breast cancer (661)
Cancer (5021)
Cardiovascular disease (430)
Career advice (1891)
Career pathing (38)
CAR-T (296)
CDC (48)
Celiac Disease (2)
Cell therapy (795)
Cervical cancer (36)
Clinical research (71849)
Collaboration (1827)
Company closure (4)
Compensation (1196)
Complete response letters (67)
COVID-19 (2811)
CRISPR (103)
C-suite (910)
Cystic fibrosis (152)
Data (6414)
Decentralized trials (2)
Denatured (40)
Depression (147)
Diabetes (515)
Diagnostics (6812)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (274)
Drug pricing (199)
Drug shortages (29)
Duchenne muscular dystrophy (247)
Earnings (91869)
Editorial (65)
Employer branding (21)
Employer resources (155)
Events (121782)
Executive appointments (1020)
FDA (20017)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (219)
Generative AI (47)
Gene therapy (653)
GLP-1 (1035)
Government (4862)
Grass and pollen (7)
Guidances (386)
Healthcare (19415)
HIV (64)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (281)
Immuno-oncology (68)
Indications (119)
Infectious disease (3097)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (123)
Intellectual property (260)
Interviews (361)
IPO (16971)
IRA (53)
Job creations (3806)
Job search strategy (1576)
JPM (66)
Kidney cancer (16)
Labor market (87)
Layoffs (589)
Leadership (34)
Legal (8150)
Liver cancer (94)
Longevity (15)
Lung cancer (682)
Lymphoma (388)
Machine learning (43)
Management (60)
Manufacturing (838)
MASH (173)
Medical device (13990)
Medtech (14046)
Mergers & acquisitions (20427)
Metabolic disorders (1351)
Multiple sclerosis (169)
NASH (21)
Neurodegenerative disease (347)
Neuropsychiatric disorders (98)
Neuroscience (3065)
Neurotech (1)
NextGen: Class of 2026 (6858)
Non-profit (4658)
Now hiring (68)
Obesity (649)
Opinion (291)
Ovarian cancer (169)
Pain (206)
Pancreatic cancer (238)
Parkinson's disease (300)
Partnered (35)
Patents (515)
Patient recruitment (514)
Peanut (58)
People (60724)
Pharmaceutical (85)
Pharmacy benefit managers (31)
Phase 1 (22585)
Phase 2 (31646)
Phase 3 (23438)
Pipeline (5532)
Policy (307)
Postmarket research (2634)
Preclinical (9651)
Press Release (67)
Prostate cancer (250)
Psychedelics (56)
Radiopharmaceuticals (304)
Rare diseases (910)
Real estate (6161)
Recruiting (72)
Regulatory (25264)
Reports (53)
Research institute (2531)
Resumes & cover letters (387)
Rett syndrome (27)
RNA editing (21)
RSV (83)
Schizophrenia (156)
Series A (258)
Series B (203)
Service/supplier (11)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (163)
Sponsored (43)
Startups (3838)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (88)
The Weekly (84)
Vaccines (1065)
Venture capital (96)
Weight loss (426)
Women's health (96)
Worklife (19)
Date
Today (144)
Last 7 days (588)
Last 30 days (2414)
Last 365 days (30829)
2026 (4127)
2025 (31169)
2024 (36384)
2023 (41111)
2022 (52404)
2021 (56922)
2020 (55180)
2019 (47818)
2018 (36042)
2017 (33302)
2016 (32699)
2015 (38753)
2014 (32493)
2013 (27415)
2012 (29483)
2011 (30159)
2010 (28267)
Location
Africa (790)
Alabama (90)
Alaska (7)
Arizona (321)
Arkansas (14)
Asia (41134)
Australia (6863)
California (11636)
Canada (3353)
China (1153)
Colorado (490)
Connecticut (504)
Delaware (345)
Europe (90884)
Florida (1725)
Georgia (366)
Hawaii (3)
Idaho (62)
Illinois (901)
India (71)
Indiana (533)
Iowa (24)
Japan (444)
Kansas (131)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1423)
Massachusetts (8453)
Michigan (330)
Minnesota (644)
Mississippi (6)
Missouri (130)
Montana (34)
Nebraska (28)
Nevada (123)
New Hampshire (84)
New Jersey (3092)
New Mexico (31)
New York (3053)
North Carolina (1558)
North Dakota (9)
Northern California (5672)
Ohio (342)
Oklahoma (21)
Oregon (45)
Pennsylvania (2334)
Puerto Rico (24)
Rhode Island (50)
South America (1159)
South Carolina (67)
South Dakota (1)
Southern California (4515)
Tennessee (178)
Texas (1789)
United States (41418)
Utah (346)
Vermont (1)
Virginia (273)
Washington D.C. (82)
Washington State (965)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
744,906 Results for "five prime therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Insightec Secures Health Canada Approval for Exablate® Prime System
February 5, 2026
·
3 min read
Press Releases
Prime Therapeutics supports FDA’s updated biosimilar recommendations
October 31, 2025
·
2 min read
Press Releases
Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer
November 14, 2025
·
3 min read
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
Drug candidates don’t usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up assets from one pharma on the cheap before being bought out for billions by another.
November 19, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
2 min read
Press Releases
Prime Therapeutics and Sempre Health Expand Innovative Behavior-Based Pricing Model to Advance Patient Affordability
October 31, 2025
·
3 min read
Press Releases
Sera Announces Publication Acceptance for PRIME Study
November 24, 2025
·
3 min read
Press Releases
Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research
February 12, 2026
·
4 min read
Mergers & acquisitions
Five Biggest Biopharma Takeovers of 2025
Four of this year’s biggest acquisitions topped 11-figure figures. One was 2025’s messiest bidding war.
January 2, 2026
·
8 min read
·
Tristan Manalac
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases.
October 27, 2025
·
2 min read
·
Tristan Manalac
1 of 74,491
Next
